| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Alberto Vaiarelli | |
| Laura Rienzi | |||
| Filippo Ubaldi | |||
| Rosario D'Anna | |||
| P2860 | cites work | Gonadotrophin-releasing hormone antagonists for assisted reproductive technology | Q24234608 |
| Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization | Q24811362 | ||
| The poor responder in IVF: is the prognosis always poor?: a systematic review | Q27005590 | ||
| Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis | Q27027912 | ||
| Predicting poor ovarian response in IVF: use of repeat basal FSH measurement | Q79963087 | ||
| Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy | Q80507370 | ||
| Iron overload is associated with low anti-müllerian hormone in women with transfusion-dependent β-thalassaemia | Q83606798 | ||
| Androgen pretreatment in poor responders undergoing controlled ovarian stimulation and in vitro fertilization treatment | Q84162662 | ||
| Poor ovarian responders: to meta-analyse or not, that is the question | Q87053884 | ||
| Absorption, distribution, metabolism and excretion of corifollitropin alfa, a recombinant hormone with a sustained follicle-stimulating activity. | Q51775041 | ||
| Serum anti-Mullerian hormone throughout the human menstrual cycle. | Q51789873 | ||
| Assessment of ovarian and uterine blood flow by transvaginal color Doppler in ovarian-stimulated women: correlation with the number of follicles and steroid hormone levels. | Q54243814 | ||
| The Bologna criteria for poor ovarian response; has the job been accomplished? | Q56981478 | ||
| The Relationship Between Anti-Müllerian Hormone in Women Receiving Fertility Assessments and Age at Menopause in Subfertile Women: Evidence From Large Population Studies | Q57910074 | ||
| Should androgen supplementation be used for poor ovarian response in IVF? | Q61237448 | ||
| Rate of severe ovarian damage following surgery for endometriomas | Q61310071 | ||
| The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response | Q67982466 | ||
| Specific insulin-like growth factor (IGF) I- and II-binding sites on rat granulosa cells: relation to IGF action | Q70014920 | ||
| Growth hormone enhances follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells | Q70127447 | ||
| Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine granulosa cells | Q70359312 | ||
| Measurement of dimeric inhibin B throughout the human menstrual cycle | Q71092025 | ||
| Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program | Q71307989 | ||
| Steroid formation by isolated and recombined ovarian granulosa and tehcal cells | Q72031197 | ||
| Hypothalamic-pituitary ageing: progressive increase in FSH and LH concentrations throughout the reproductive life in regularly menstruating women | Q72711907 | ||
| In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cells | Q72816918 | ||
| Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility | Q73180929 | ||
| Serum inhibins A and B fall differentially as FSH rises in perimenopausal women | Q77130387 | ||
| Female reproductive aging is marked by decreased secretion of dimeric inhibin | Q77909547 | ||
| Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study | Q28168925 | ||
| Recurrent implantation failure in assisted reproduction: how to counsel and manage. B. Treatment options that have not been proven to benefit the couple | Q28192087 | ||
| Low-dose aspirin use does not improve in vitro fertilization outcomes in poor responders | Q28218056 | ||
| Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis | Q28220366 | ||
| Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care | Q28269659 | ||
| Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis | Q30636404 | ||
| Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis | Q33306633 | ||
| Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. | Q33587150 | ||
| A rational approach to the management of low responders in in-vitro fertilization | Q33685324 | ||
| Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program | Q33787113 | ||
| Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques | Q33872072 | ||
| Advanced reproductive age and fertility | Q34074247 | ||
| Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis | Q34141154 | ||
| A systematic review of tests predicting ovarian reserve and IVF outcome | Q34554644 | ||
| Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: a systematic review and meta-analysis | Q34560963 | ||
| GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis | Q34573314 | ||
| Endometriosis and infertility: pathophysiology and management | Q34622946 | ||
| Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies | Q34984512 | ||
| Management of poor responders in IVF. | Q36095001 | ||
| The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couples | Q36970298 | ||
| How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis | Q37221297 | ||
| Androgens stimulate early stages of follicular growth in the primate ovary | Q37383118 | ||
| Medical adjuncts in IVF: evidence for clinical practice | Q37426429 | ||
| Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. | Q37533861 | ||
| Primary ovarian insufficiency | Q37779848 | ||
| Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF. | Q37903556 | ||
| A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? | Q37950634 | ||
| The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. | Q37981575 | ||
| The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis | Q37988079 | ||
| The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis | Q38020810 | ||
| Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols? | Q39225107 | ||
| Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function | Q39495901 | ||
| Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria | Q39559710 | ||
| In women with endometriosis anti-Müllerian hormone levels are decreased only in those with previous endometrioma surgery. | Q39581951 | ||
| Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. | Q50643259 | ||
| Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. | Q50722776 | ||
| Direct effect of gonadotropin-releasing hormone agonists on the rabbit ovarian follicle | Q50792967 | ||
| Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization | Q50798590 | ||
| Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG | Q50801664 | ||
| ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria | Q39759151 | ||
| Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles | Q40578144 | ||
| Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization | Q40794038 | ||
| High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome | Q40977184 | ||
| Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause | Q41105050 | ||
| Assisted conception following poor ovarian response to gonadotrophin stimulation | Q41483448 | ||
| Mature oocyte cryopreservation: a guideline | Q41605286 | ||
| Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study | Q41606292 | ||
| Accumulation of oocytes: a new strategy for managing low-responder patients | Q41606404 | ||
| Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels | Q42491998 | ||
| High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial | Q42495276 | ||
| Long-term effects of uterine fibroid embolization on ovarian reserve: a prospective cohort study | Q43194348 | ||
| Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase--a function of improved embryo quality | Q43657861 | ||
| Young age does not protect against the adverse effects of reduced ovarian reserve--an eight year study | Q44013160 | ||
| Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology. | Q44312594 | ||
| Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists | Q44673984 | ||
| Effect of androgen levels on in vitro fertilization cycles | Q44933370 | ||
| High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients | Q44960908 | ||
| High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization | Q45002539 | ||
| Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders | Q45111450 | ||
| Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus. | Q45915635 | ||
| Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization | Q46047359 | ||
| Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: a prospective, randomized study. | Q46869654 | ||
| Addition of GnRH antagonist in cycles of poor responders undergoing IVF. | Q47587071 | ||
| Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol | Q47811678 | ||
| Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations | Q47856150 | ||
| Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial | Q47860850 | ||
| What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders? | Q48003610 | ||
| Ovarian estradiol production in vivo. Inhibitory effect of leuprolide acetate. | Q48018435 | ||
| Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI. | Q48607501 | ||
| Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonis | Q48626458 | ||
| Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study | Q48629671 | ||
| Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study | Q48637726 | ||
| Medical hypophysectomy: I. Dose-response using a gonadotropin-releasing hormone antagonist | Q48652193 | ||
| Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction | Q48685133 | ||
| Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles | Q48738683 | ||
| Hopes and facts about mild ovarian stimulation | Q48789180 | ||
| Gonadotropin stimulation following GnRH-a priming for poor responders in in vitro fertilization-embryo transfer programs | Q48891078 | ||
| Microdose follicular phase gonadotropin-releasing hormone agonist (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization | Q48904140 | ||
| Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay | Q48919073 | ||
| Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile? | Q48919884 | ||
| Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle | Q48943045 | ||
| The relationship between ovarian vascularity and the duration of stimulation in in-vitro fertilization | Q48957361 | ||
| Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization | Q48959041 | ||
| Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation | Q48982981 | ||
| Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders | Q49015847 | ||
| Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study | Q49073122 | ||
| A double-blind cross-over controlled study to evaluate the effect of human biosynthetic growth hormone on ovarian stimulation in previous poor responders to in-vitro fertilization | Q49119818 | ||
| Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study | Q49151564 | ||
| The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials | Q49162266 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endocrine system | Q11078 |
| premature ovarian failure | Q647630 | ||
| genitourinary system | Q4712977 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 352098 | |
| P577 | publication date | 2014-07-20 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Management of poor responders in IVF: is there anything new? | |
| P478 | volume | 2014 |
| Q48505636 | A comparison of treatment results of the different treatment protocols in patients with poor ovarian response |
| Q37244112 | Anti Mullerian Hormone: Ovarian response indicator in young patients receiving Long GnRH Agonist Protocol for Ovarian Stimulation. |
| Q90716516 | Assessing the practice of LuPOR for poor responders: a prospective study evaluating follicular fluid cfDNA levels during natural IVF cycles |
| Q37593698 | Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone |
| Q56961316 | Clinical analyses of successful and previously failed intracytoplasmic sperm injection cycle parameters in patients with poor ovarian reserve |
| Q28831445 | Comparison Pregnancy Outcomes Between Minimal Stimulation Protocol and Conventional GnRH Antagonist Protocols in Poor Ovarian Responders |
| Q64095767 | Comparison of GnRH agonist versus luteal estradiol GnRH antagonist protocol using transdermal testosterone in poor responders |
| Q97530563 | Corifollitropin alfa for poor responders patients, a prospective randomized study |
| Q48516030 | Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study |
| Q60929796 | Does the "delayed start" protocol with gonadotropin-releasing hormone antagonist improve the pregnancy outcome in Bologna poor responders? a randomized clinical trial |
| Q55428711 | Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis. |
| Q60921155 | Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve |
| Q35844053 | Efficacy and Safety of Pergoveris in Assisted Reproductive Technology--ESPART: rationale and design of a randomised controlled trial in poor ovarian responders undergoing IVF/ICSI treatment |
| Q48161909 | Efficacy of luteal estrogen administration and an early follicular Gonadotropin-releasing hormone antagonist priming protocol in poor responders undergoing in vitro fertilization. |
| Q62631879 | Evaluation of the Second Follicular Wave Phenomenon in Natural Cycle Assisted Reproduction: A Key Option for Poor Responders through Luteal Phase Oocyte Retrieval |
| Q57176379 | Fertility Preservation: Current and Future Perspectives for Oncologic Patients at Risk for Iatrogenic Premature Ovarian Insufficiency |
| Q38813235 | Fertility in midlife women |
| Q37723576 | Mid-luteal estradiol levels of poor/good responders and intracytoplasmic sperm injection |
| Q37549498 | Morphokinetic Characteristics and Developmental Potential of In Vitro Cultured Embryos from Natural Cycles in Patients with Poor Ovarian Response |
| Q26779481 | New Frontier in Glycoprotein Hormones and Their Receptors Structure-Function |
| Q41597978 | Optimal embryo transfer strategy in poor response may include freeze-all |
| Q92442735 | Ovarian stimulation modalities in poor responders |
| Q26744379 | Poor ovarian reserve |
| Q48578593 | Prediction of different ovarian responses using anti-Müllerian hormone following a long agonist treatment protocol for IVF. |
| Q55253420 | Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. |
| Q48035385 | Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserve. |
| Q36337216 | The Ideal Stimulation Protocol: Is There One? |
| Q35707971 | The Role of Overweight and Obesity in In Vitro Fertilization Outcomes of Poor Ovarian Responders |
| Q38371873 | The role of gene polymorphisms and AMH level in prediction of poor ovarian response in Egyptian women undergoing IVF procedure |
| Q98727205 | Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept |
Search more.